| Autor: |
Wani, Wasim A., Dar, Sheeraz A., Mir, Mudasir N., Bhat, Javeed I., Charoo, Bashir A. |
| Předmět: |
|
| Zdroj: |
National Journal of Medical Research; 2019, Vol. 9 Issue 1, p48-50, 3p |
| Abstrakt: |
Objective: The objective of the study was to find out effect of inhaled corticosteroids on HbA1c. Methods: Asthma patients in the age group 5-15 years who were started on moderate doses of inhaled budesonide (400-800 microgram/day) for the first time were selected for the study. HbA1c level was measured before initiating inhaled corticosteroids (ICS) and after 6 months using venous blood samples. Results: The mean (SD) HbA1c levels before and after 6 months of starting inhaled corticosteroids was 4.75(0.16) and 5.25(0.29) respectively. The difference was statistically significant (p value <0.0001). After 6 months of inhaler use, HbA1c level of 5 patients (8.33%) reached at high risk level (5.7-6.4%). Conclusion: inhaled corticosteroids have a significant effect onHbA1c level after prolonged usage. We recommend monitoring HbA1c levels in children on long term inhaled corticosteroids. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
